North America dominates the global market for plasma fraction due to rise in neurological and autoimmune disorders, and increasing geriatric population in the region. Asia is expected to show high growth rates in the next five years in the global plasma fraction market, with China and India being the fastest-growing markets in the Asia Pacific region. The key driving forces for the plasma fraction market in developing countries are the large pool of patients, increasing awareness about the disease, increasing disposable income, rising number of hemophilic patients, increasing organ transplantation, increasing use of immunoglobulins, and rising government funding in the region.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4258
Increasing number of hemophilic patients, rise in geriatric population, increase in healthcare awareness and expenditure, growing off-label use of albumin and immunoglobulin in various chronic diseases, increased diagnosis rate of diseases, rise in the use of prophylactic treatment for bleeding and immune diseases, and increasing disposable income in developing countries are some of the key factors driving the growth of the global plasma fraction market. However, strict government regulations, high cost and limited reimbursement, economic slowdown, and rising number of recombinant products act as major restraints for the growth of the global plasma fraction market.
Some of the major trends in the global plasma fraction market are increasing market consolidation, rising adoption of subcutaneous Ig ScIg therapy, increasing number of local players, and rising number of plasma fraction collection centers.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4258
The major companies operating in the global plasma fraction market are Baxter International, Inc., Octapharma AG, Biotest AG, CSL, Ltd., Grifols International S.A., Kedrion S.p.A., LFB S.A., Chinese Biological Products, Inc., and Shanghai RAAS Blood Products Co., Ltd.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353